

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.59358725 |
| 2 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 8.88122666 |
| 3 | regulation of natural killer cell mediated immunity (GO:0002715) | 8.88122666 |
| 4 | DNA deamination (GO:0045006) | 8.60781055 |
| 5 | cellular response to interleukin-15 (GO:0071350) | 8.01291595 |
| 6 | activated T cell proliferation (GO:0050798) | 7.97180844 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.76072276 |
| 8 | cellular defense response (GO:0006968) | 7.31569552 |
| 9 | negative T cell selection (GO:0043383) | 7.22240035 |
| 10 | response to interleukin-15 (GO:0070672) | 7.10684187 |
| 11 | negative thymic T cell selection (GO:0045060) | 6.98223142 |
| 12 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.95724003 |
| 13 | T cell migration (GO:0072678) | 6.90223576 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.66583975 |
| 15 | negative regulation of cell killing (GO:0031342) | 6.66583975 |
| 16 | * cytolysis (GO:0019835) | 6.34366988 |
| 17 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 6.26142316 |
| 18 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 6.26142316 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.20375811 |
| 20 | positive thymic T cell selection (GO:0045059) | 6.19912445 |
| 21 | thymic T cell selection (GO:0045061) | 5.80272648 |
| 22 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 5.76231452 |
| 23 | positive T cell selection (GO:0043368) | 5.76081710 |
| 24 | natural killer cell activation (GO:0030101) | 5.71356748 |
| 25 | positive regulation of isotype switching (GO:0045830) | 5.52626652 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 5.49329995 |
| 27 | actin nucleation (GO:0045010) | 5.31735082 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.26694263 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.26694263 |
| 30 | regulation of cell killing (GO:0031341) | 5.25515796 |
| 31 | leukocyte aggregation (GO:0070486) | 5.13990933 |
| 32 | heterotypic cell-cell adhesion (GO:0034113) | 5.05252358 |
| 33 | T cell selection (GO:0045058) | 4.96510613 |
| 34 | sequestering of actin monomers (GO:0042989) | 4.91086971 |
| 35 | negative regulation of T cell apoptotic process (GO:0070233) | 4.84657455 |
| 36 | negative regulation of viral genome replication (GO:0045071) | 4.81468118 |
| 37 | regulation of activation of Janus kinase activity (GO:0010533) | 4.78816625 |
| 38 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.76425124 |
| 39 | positive regulation of DNA recombination (GO:0045911) | 4.73891685 |
| 40 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.70311898 |
| 41 | leukocyte cell-cell adhesion (GO:0007159) | 4.70074011 |
| 42 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.59492963 |
| 43 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.57513436 |
| 44 | T cell costimulation (GO:0031295) | 4.55585328 |
| 45 | lymphocyte costimulation (GO:0031294) | 4.54812361 |
| 46 | lymphocyte migration (GO:0072676) | 4.45174341 |
| 47 | regulation of isotype switching (GO:0045191) | 4.40732163 |
| 48 | positive regulation of B cell mediated immunity (GO:0002714) | 4.39202460 |
| 49 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.39202460 |
| 50 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.38142896 |
| 51 | T cell receptor signaling pathway (GO:0050852) | 4.33016438 |
| 52 | regulation of regulatory T cell differentiation (GO:0045589) | 4.30506474 |
| 53 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.28053014 |
| 54 | positive regulation of cell killing (GO:0031343) | 4.27815616 |
| 55 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.25834253 |
| 56 | negative regulation of stress fiber assembly (GO:0051497) | 4.23033794 |
| 57 | negative regulation of T cell mediated immunity (GO:0002710) | 4.21079284 |
| 58 | positive regulation of tolerance induction (GO:0002645) | 4.10654283 |
| 59 | lymphocyte chemotaxis (GO:0048247) | 4.09373289 |
| 60 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.09046090 |
| 61 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.09046090 |
| 62 | T cell differentiation involved in immune response (GO:0002292) | 4.09046090 |
| 63 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.03787967 |
| 64 | eosinophil chemotaxis (GO:0048245) | 3.97363844 |
| 65 | negative regulation by host of viral transcription (GO:0043922) | 3.97166617 |
| 66 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.96938432 |
| 67 | macrophage chemotaxis (GO:0048246) | 3.96767855 |
| 68 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.92506932 |
| 69 | leukocyte tethering or rolling (GO:0050901) | 3.91594875 |
| 70 | mast cell activation (GO:0045576) | 3.91251068 |
| 71 | positive regulation of immunoglobulin production (GO:0002639) | 3.87306287 |
| 72 | positive regulation of B cell differentiation (GO:0045579) | 3.83837281 |
| 73 | alpha-beta T cell activation (GO:0046631) | 3.80693128 |
| 74 | T cell activation involved in immune response (GO:0002286) | 3.80294155 |
| 75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.72733121 |
| 76 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.71671718 |
| 77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.70702766 |
| 78 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.69794678 |
| 79 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.68644122 |
| 80 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.68434114 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.65205925 |
| 82 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.65113719 |
| 83 | regulation of response to interferon-gamma (GO:0060330) | 3.61811820 |
| 84 | regulation of hypersensitivity (GO:0002883) | 3.60496146 |
| 85 | eosinophil migration (GO:0072677) | 3.60464570 |
| 86 | alpha-beta T cell differentiation (GO:0046632) | 3.58850689 |
| 87 | regulation of B cell mediated immunity (GO:0002712) | 3.58253924 |
| 88 | T cell proliferation (GO:0042098) | 3.54000619 |
| 89 | regulation of tolerance induction (GO:0002643) | 3.53893238 |
| 90 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.52825854 |
| 91 | substrate-dependent cell migration (GO:0006929) | 3.52278648 |
| 92 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.50498399 |
| 93 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.46706374 |
| 94 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.44309608 |
| 95 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.44220010 |
| 96 | regulation of viral genome replication (GO:0045069) | 3.43563310 |
| 97 | regulation of B cell differentiation (GO:0045577) | 3.43016838 |
| 98 | T cell differentiation (GO:0030217) | 3.42488426 |
| 99 | positive regulation of defense response to virus by host (GO:0002230) | 3.41530970 |
| 100 | positive regulation of interleukin-4 production (GO:0032753) | 3.40734819 |
| 101 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.40538508 |
| 102 | regulation of T cell apoptotic process (GO:0070232) | 3.38371849 |
| 103 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.37968209 |
| 104 | T-helper cell differentiation (GO:0042093) | 3.37968209 |
| 105 | regulation of calcium-mediated signaling (GO:0050848) | 3.37143860 |
| 106 | T cell activation (GO:0042110) | 3.30386537 |
| 107 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.29227190 |
| 108 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.28022093 |
| 109 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.25993026 |
| 110 | regulation of immunoglobulin production (GO:0002637) | 3.21621116 |
| 111 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.21212436 |
| 112 | positive regulation of lymphocyte migration (GO:2000403) | 3.21187949 |
| 113 | response to protozoan (GO:0001562) | 3.21107289 |
| 114 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.20548567 |
| 115 | chemokine-mediated signaling pathway (GO:0070098) | 3.19569886 |
| 116 | regulation of T cell tolerance induction (GO:0002664) | 3.18882558 |
| 117 | respiratory burst (GO:0045730) | 3.17113974 |
| 118 | regulation of interleukin-8 secretion (GO:2000482) | 3.16551928 |
| 119 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.14497738 |
| 120 | dendritic cell chemotaxis (GO:0002407) | 3.14471860 |
| 121 | regulation of leukocyte mediated immunity (GO:0002703) | 3.14203886 |
| 122 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.13982861 |
| 123 | response to interferon-beta (GO:0035456) | 3.11663096 |
| 124 | negative regulation of interleukin-12 production (GO:0032695) | 3.10391139 |
| 125 | positive regulation of lamellipodium assembly (GO:0010592) | 3.09494313 |
| 126 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.08053605 |
| 127 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.06666104 |
| 128 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.06172802 |
| 129 | B cell receptor signaling pathway (GO:0050853) | 3.05986982 |
| 130 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.05965868 |
| 131 | regulation of defense response to virus by virus (GO:0050690) | 3.04120162 |
| 132 | regulation of T cell chemotaxis (GO:0010819) | 3.00567790 |
| 133 | positive regulation of T cell chemotaxis (GO:0010820) | 3.00567790 |
| 134 | immunoglobulin mediated immune response (GO:0016064) | 3.00414299 |
| 135 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.00309626 |
| 136 | T cell homeostasis (GO:0043029) | 2.94894581 |
| 137 | negative regulation of viral process (GO:0048525) | 2.93507370 |
| 138 | positive regulation of leukocyte mediated immunity (GO:0002705) | 2.91731749 |
| 139 | positive regulation of T cell apoptotic process (GO:0070234) | 2.91119086 |
| 140 | hypotonic response (GO:0006971) | 2.90704564 |
| 141 | positive regulation of humoral immune response (GO:0002922) | 2.90334753 |
| 142 | regulation of chronic inflammatory response (GO:0002676) | 2.89476314 |
| 143 | cytidine metabolic process (GO:0046087) | 10.7258425 |
| 144 | cytidine catabolic process (GO:0006216) | 10.7258425 |
| 145 | cytidine deamination (GO:0009972) | 10.7258425 |
| 146 | interferon-gamma production (GO:0032609) | 10.5053323 |
| 147 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 10.1192189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.47968919 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.56239225 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.30514909 |
| 4 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.54464496 |
| 5 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.39302934 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.06330374 |
| 7 | MYB_26560356_Chip-Seq_TH2_Human | 3.73098426 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.50731850 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.30420320 |
| 10 | * MAF_26560356_Chip-Seq_TH1_Human | 3.06420178 |
| 11 | MYB_26560356_Chip-Seq_TH1_Human | 2.97781552 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.93105946 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.91201180 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.87261431 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.86458145 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.78830270 |
| 17 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.74909597 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.71877151 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.54893206 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.50166412 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.48358959 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.44884096 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28508670 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.25883624 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23848011 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.23488895 |
| 27 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.22964211 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.18323334 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.09360813 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.08682394 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07609376 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.03867991 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95230921 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.95214284 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94485956 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.92135079 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.86505197 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85559153 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.81402885 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76246531 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76050038 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75153928 |
| 43 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70278274 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65872925 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65209145 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61305523 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61091738 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56392075 |
| 49 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.56258982 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53917180 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52697476 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48084438 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45867348 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.45206266 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36749512 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33904565 |
| 57 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.33427511 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33385231 |
| 59 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.33165867 |
| 60 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.31946564 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.31011521 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28828175 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26669024 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23642420 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.23128388 |
| 66 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21588331 |
| 67 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19472798 |
| 68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19151163 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16813030 |
| 70 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15779132 |
| 71 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.13421530 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11996984 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10206624 |
| 74 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.09999489 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08626205 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06664541 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06471066 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06387824 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06114967 |
| 80 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.03943218 |
| 81 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02527789 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01961871 |
| 83 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.00092998 |
| 84 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00000174 |
| 85 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99377386 |
| 86 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99091161 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98536416 |
| 88 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.98497564 |
| 89 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.97268980 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.96559296 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95187650 |
| 92 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94651956 |
| 93 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.94134120 |
| 94 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93395401 |
| 95 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93254547 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92436114 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92328353 |
| 98 | P300_27268052_Chip-Seq_Bcells_Human | 0.92255258 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91845271 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91153886 |
| 101 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.90440282 |
| 102 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88828107 |
| 103 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88576660 |
| 104 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.87424691 |
| 105 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87106304 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87083280 |
| 107 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86352058 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85881976 |
| 109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85316890 |
| 110 | GATA3_26560356_Chip-Seq_TH1_Human | 0.82651874 |
| 111 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.82531802 |
| 112 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.80308144 |
| 113 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.80308144 |
| 114 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.79682166 |
| 115 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.79557716 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79244356 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78717438 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78536707 |
| 119 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78168639 |
| 120 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.77469943 |
| 121 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.77043431 |
| 122 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76739756 |
| 123 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.76577942 |
| 124 | AR_20517297_ChIP-Seq_VCAP_Human | 0.76024059 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75974038 |
| 126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75942130 |
| 127 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.75925353 |
| 128 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.75026604 |
| 129 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.73909876 |
| 130 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.73196603 |
| 131 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.72514326 |
| 132 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.72243931 |
| 133 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.70487251 |
| 134 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.70346359 |
| 135 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69461255 |
| 136 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.68990343 |
| 137 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68525361 |
| 138 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.68320962 |
| 139 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67673805 |
| 140 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.67495034 |
| 141 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.67200621 |
| 142 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65428893 |
| 143 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.64793058 |
| 144 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.63834436 |
| 145 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63242289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 7.05415591 |
| 2 | MP0006082_CNS_inflammation | 6.35529277 |
| 3 | MP0003763_abnormal_thymus_physiology | 4.14321074 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.24746904 |
| 5 | MP0001800_abnormal_humoral_immune | 3.22301281 |
| 6 | MP0001873_stomach_inflammation | 3.19713433 |
| 7 | MP0009785_altered_susceptibility_to | 3.09908403 |
| 8 | * MP0002420_abnormal_adaptive_immunity | 2.89775062 |
| 9 | * MP0001819_abnormal_immune_cell | 2.85130303 |
| 10 | * MP0005025_abnormal_response_to | 2.81861426 |
| 11 | MP0000858_altered_metastatic_potential | 2.76340742 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.72406368 |
| 13 | MP0002723_abnormal_immune_serum | 2.69527590 |
| 14 | MP0001790_abnormal_immune_system | 2.66927561 |
| 15 | MP0005387_immune_system_phenotype | 2.66927561 |
| 16 | MP0002398_abnormal_bone_marrow | 2.62807233 |
| 17 | MP0000685_abnormal_immune_system | 2.56986094 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.50733392 |
| 19 | * MP0003448_altered_tumor_morphology | 2.45587335 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.44158227 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.36258655 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.36038625 |
| 23 | MP0000716_abnormal_immune_system | 2.32083682 |
| 24 | MP0010307_abnormal_tumor_latency | 2.28963113 |
| 25 | MP0002722_abnormal_immune_system | 2.15010044 |
| 26 | MP0004947_skin_inflammation | 2.09322534 |
| 27 | MP0002405_respiratory_system_inflammati | 2.07946781 |
| 28 | MP0003950_abnormal_plasma_membrane | 2.05688337 |
| 29 | MP0002006_tumorigenesis | 2.04121849 |
| 30 | MP0002132_abnormal_respiratory_system | 2.03291527 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.93770171 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.91341065 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.90975518 |
| 34 | MP0002429_abnormal_blood_cell | 1.85821115 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.84997674 |
| 36 | MP0003866_abnormal_defecation | 1.76651616 |
| 37 | MP0003724_increased_susceptibility_to | 1.75577306 |
| 38 | MP0002419_abnormal_innate_immunity | 1.71069575 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.69727040 |
| 40 | MP0002933_joint_inflammation | 1.65641466 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.64713081 |
| 42 | MP0003303_peritoneal_inflammation | 1.55454960 |
| 43 | MP0001851_eye_inflammation | 1.37508915 |
| 44 | MP0003436_decreased_susceptibility_to | 1.37439757 |
| 45 | MP0008469_abnormal_protein_level | 1.35533168 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.32332004 |
| 47 | MP0002019_abnormal_tumor_incidence | 1.27689746 |
| 48 | MP0005310_abnormal_salivary_gland | 1.26173459 |
| 49 | MP0003045_fibrosis | 1.21247160 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.18356651 |
| 51 | MP0000490_abnormal_crypts_of | 1.17216914 |
| 52 | MP0003646_muscle_fatigue | 1.10736445 |
| 53 | MP0005166_decreased_susceptibility_to | 1.10388450 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.09455622 |
| 55 | MP0000920_abnormal_myelination | 1.06653928 |
| 56 | MP0009764_decreased_sensitivity_to | 1.05037487 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.01115033 |
| 58 | MP0005377_hearing/vestibular/ear_phenot | 1.00686297 |
| 59 | MP0003878_abnormal_ear_physiology | 1.00686297 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.00557900 |
| 61 | MP0003786_premature_aging | 0.97480663 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 0.96233149 |
| 63 | MP0001919_abnormal_reproductive_system | 0.96221311 |
| 64 | MP0001853_heart_inflammation | 0.95932956 |
| 65 | MP0001533_abnormal_skeleton_physiology | 0.93458413 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 0.93294766 |
| 67 | MP0003172_abnormal_lysosome_physiology | 0.87194696 |
| 68 | * MP0009763_increased_sensitivity_to | 0.85183342 |
| 69 | MP0004510_myositis | 0.81241999 |
| 70 | MP0003566_abnormal_cell_adhesion | 0.79294338 |
| 71 | MP0008873_increased_physiological_sensi | 0.79038048 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 0.78147238 |
| 73 | MP0001545_abnormal_hematopoietic_system | 0.78147238 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.77720861 |
| 75 | MP0005083_abnormal_biliary_tract | 0.74369506 |
| 76 | MP0008057_abnormal_DNA_replication | 0.74338870 |
| 77 | MP0002163_abnormal_gland_morphology | 0.73787799 |
| 78 | MP0003137_abnormal_impulse_conducting | 0.72114102 |
| 79 | MP0008872_abnormal_physiological_respon | 0.72016110 |
| 80 | MP0001905_abnormal_dopamine_level | 0.71919301 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.71476395 |
| 82 | MP0005023_abnormal_wound_healing | 0.70865033 |
| 83 | MP0002102_abnormal_ear_morphology | 0.69444700 |
| 84 | MP0004145_abnormal_muscle_electrophysio | 0.67460269 |
| 85 | MP0004957_abnormal_blastocyst_morpholog | 0.67232720 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.65704875 |
| 87 | MP0003075_altered_response_to | 0.63760534 |
| 88 | MP0001663_abnormal_digestive_system | 0.62751880 |
| 89 | MP0003690_abnormal_glial_cell | 0.62643240 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 0.62419647 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60166840 |
| 92 | MP0001542_abnormal_bone_strength | 0.59226884 |
| 93 | MP0001765_abnormal_ion_homeostasis | 0.58569813 |
| 94 | MP0000609_abnormal_liver_physiology | 0.58472124 |
| 95 | MP0006072_abnormal_retinal_apoptosis | 0.58362272 |
| 96 | MP0005389_reproductive_system_phenotype | 0.57579084 |
| 97 | MP0004883_abnormal_blood_vessel | 0.56941456 |
| 98 | MP0002009_preneoplasia | 0.56820734 |
| 99 | MP0002168_other_aberrant_phenotype | 0.54767425 |
| 100 | MP0003252_abnormal_bile_duct | 0.53837589 |
| 101 | MP0000343_altered_response_to | 0.53646408 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.52310307 |
| 103 | MP0000477_abnormal_intestine_morphology | 0.52090287 |
| 104 | MP0010234_abnormal_vibrissa_follicle | 0.51686947 |
| 105 | MP0002693_abnormal_pancreas_physiology | 0.50288122 |
| 106 | MP0003693_abnormal_embryo_hatching | 0.50209348 |
| 107 | MP0002736_abnormal_nociception_after | 0.48877993 |
| 108 | MP0001968_abnormal_touch/_nociception | 0.48539108 |
| 109 | MP0002095_abnormal_skin_pigmentation | 0.48025296 |
| 110 | MP0000613_abnormal_salivary_gland | 0.47307121 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.47236855 |
| 112 | MP0003795_abnormal_bone_structure | 0.47068794 |
| 113 | MP0006054_spinal_hemorrhage | 0.46904527 |
| 114 | MP0004381_abnormal_hair_follicle | 0.46261371 |
| 115 | MP0005076_abnormal_cell_differentiation | 0.45572310 |
| 116 | MP0004130_abnormal_muscle_cell | 0.45520322 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.45160989 |
| 118 | MP0002638_abnormal_pupillary_reflex | 0.45070417 |
| 119 | MP0005390_skeleton_phenotype | 0.44644202 |
| 120 | MP0003279_aneurysm | 0.44352456 |
| 121 | MP0005636_abnormal_mineral_homeostasis | 0.43824262 |
| 122 | MP0001501_abnormal_sleep_pattern | 0.43691718 |
| 123 | MP0000249_abnormal_blood_vessel | 0.43196975 |
| 124 | MP0001119_abnormal_female_reproductive | 0.42849205 |
| 125 | MP0002083_premature_death | 0.42494352 |
| 126 | MP0008875_abnormal_xenobiotic_pharmacok | 0.42242482 |
| 127 | MP0009642_abnormal_blood_homeostasis | 0.41670996 |
| 128 | MP0001191_abnormal_skin_condition | 0.41562051 |
| 129 | MP0002086_abnormal_extraembryonic_tissu | 0.41071364 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.40907992 |
| 131 | MP0005360_urolithiasis | 0.39694458 |
| 132 | MP0003329_amyloid_beta_deposits | 0.37057877 |
| 133 | MP0008770_decreased_survivor_rate | 0.36649854 |
| 134 | MP0003943_abnormal_hepatobiliary_system | 0.34235903 |
| 135 | MP0000604_amyloidosis | 0.33504528 |
| 136 | MP0000367_abnormal_coat/_hair | 0.32766723 |
| 137 | MP0009643_abnormal_urine_homeostasis | 0.32299613 |
| 138 | MP0001243_abnormal_dermal_layer | 0.31416555 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.31139243 |
| 140 | MP0005075_abnormal_melanosome_morpholog | 0.29819105 |
| 141 | MP0009278_abnormal_bone_marrow | 0.28968047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 7.01480585 |
| 2 | T lymphocytopenia (HP:0005403) | 6.52935060 |
| 3 | Encephalitis (HP:0002383) | 6.46107415 |
| 4 | Hemiplegia (HP:0002301) | 6.22696353 |
| 5 | Abnormality of T cell number (HP:0011839) | 6.22415803 |
| 6 | Optic neuritis (HP:0100653) | 6.06405996 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 6.06405996 |
| 8 | Myositis (HP:0100614) | 5.85936801 |
| 9 | Hypoproteinemia (HP:0003075) | 5.81246719 |
| 10 | Nasal polyposis (HP:0100582) | 5.66458821 |
| 11 | Orchitis (HP:0100796) | 5.38447490 |
| 12 | Keratoconjunctivitis sicca (HP:0001097) | 4.70528838 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 4.60779927 |
| 14 | Meningitis (HP:0001287) | 4.56882612 |
| 15 | Tetraplegia (HP:0002445) | 4.56405714 |
| 16 | Abnormality of macrophages (HP:0004311) | 4.50552935 |
| 17 | Joint swelling (HP:0001386) | 4.49515159 |
| 18 | Increased serum ferritin (HP:0003281) | 4.35703693 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.33389328 |
| 20 | Keratoconjunctivitis (HP:0001096) | 4.23995407 |
| 21 | Abnormality of T cells (HP:0002843) | 4.05554244 |
| 22 | Chronic diarrhea (HP:0002028) | 4.00090666 |
| 23 | Stomatitis (HP:0010280) | 3.89605183 |
| 24 | Increased CSF protein (HP:0002922) | 3.70809484 |
| 25 | Pulmonary embolism (HP:0002204) | 3.64979798 |
| 26 | Abnormality of iron homeostasis (HP:0011031) | 3.60118996 |
| 27 | Thyroiditis (HP:0100646) | 3.48477747 |
| 28 | Abnormal albumin level (HP:0012116) | 3.42101983 |
| 29 | Hypoalbuminemia (HP:0003073) | 3.42101983 |
| 30 | Acute hepatic failure (HP:0006554) | 3.37079588 |
| 31 | Pulmonary infiltrates (HP:0002113) | 3.35905135 |
| 32 | Arterial thrombosis (HP:0004420) | 3.27509346 |
| 33 | IgM deficiency (HP:0002850) | 3.23097198 |
| 34 | Gangrene (HP:0100758) | 3.18525765 |
| 35 | Hemoptysis (HP:0002105) | 3.14043801 |
| 36 | Vasculitis (HP:0002633) | 3.13138257 |
| 37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.11666900 |
| 38 | Combined immunodeficiency (HP:0005387) | 3.09697825 |
| 39 | Abnormality of B cell number (HP:0010975) | 3.09004422 |
| 40 | Recurrent viral infections (HP:0004429) | 3.08098423 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.07158678 |
| 42 | Recurrent cutaneous fungal infections (HP:0011370) | 3.07158678 |
| 43 | Pancytopenia (HP:0001876) | 3.06532597 |
| 44 | Severe combined immunodeficiency (HP:0004430) | 3.03357455 |
| 45 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.02334217 |
| 46 | Spontaneous hematomas (HP:0007420) | 3.01783405 |
| 47 | Obstructive lung disease (HP:0006536) | 2.99177659 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99177659 |
| 49 | Recurrent abscess formation (HP:0002722) | 2.98227659 |
| 50 | Abnormality of oral frenula (HP:0000190) | 2.97430736 |
| 51 | Amyotrophic lateral sclerosis (HP:0007354) | 2.95392365 |
| 52 | Recurrent bronchitis (HP:0002837) | 2.94743194 |
| 53 | Chronic otitis media (HP:0000389) | 2.90825854 |
| 54 | Ureteral stenosis (HP:0000071) | 2.88905154 |
| 55 | B lymphocytopenia (HP:0010976) | 2.87268214 |
| 56 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.86950331 |
| 57 | Eczematoid dermatitis (HP:0000976) | 2.85766422 |
| 58 | Hyponatremia (HP:0002902) | 2.77961110 |
| 59 | Recurrent bacterial skin infections (HP:0005406) | 2.74781446 |
| 60 | Increased intracranial pressure (HP:0002516) | 2.73205294 |
| 61 | Abnormality of intracranial pressure (HP:0012640) | 2.73205294 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.70305483 |
| 63 | Abnormality of the fingertips (HP:0001211) | 2.67398634 |
| 64 | Inflammation of the large intestine (HP:0002037) | 2.64144143 |
| 65 | Increased intramyocellular lipid droplets (HP:0012240) | 2.61794231 |
| 66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.61447301 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.60697942 |
| 68 | Increased IgM level (HP:0003496) | 2.60378894 |
| 69 | Ureteral obstruction (HP:0006000) | 2.59696650 |
| 70 | Chest pain (HP:0100749) | 2.58575895 |
| 71 | Eosinophilia (HP:0001880) | 2.57292980 |
| 72 | Lymphoma (HP:0002665) | 2.56212115 |
| 73 | Hypoplasia of the thymus (HP:0000778) | 2.55196218 |
| 74 | Anorexia (HP:0002039) | 2.54604657 |
| 75 | Leukocytosis (HP:0001974) | 2.54490142 |
| 76 | Pustule (HP:0200039) | 2.52427250 |
| 77 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.52303021 |
| 78 | Recurrent skin infections (HP:0001581) | 2.47969995 |
| 79 | Hypertriglyceridemia (HP:0002155) | 2.46620429 |
| 80 | Abnormality of the prostate (HP:0008775) | 2.45067609 |
| 81 | Epistaxis (HP:0000421) | 2.43967367 |
| 82 | IgG deficiency (HP:0004315) | 2.43720364 |
| 83 | Increased IgE level (HP:0003212) | 2.42184614 |
| 84 | Gastrointestinal infarctions (HP:0005244) | 2.40967461 |
| 85 | Glomerulopathy (HP:0100820) | 2.39391192 |
| 86 | Abnormal platelet volume (HP:0011876) | 2.39054679 |
| 87 | Abnormality of eosinophils (HP:0001879) | 2.38881700 |
| 88 | Mitochondrial inheritance (HP:0001427) | 2.35384962 |
| 89 | Bronchitis (HP:0012387) | 2.34582518 |
| 90 | Panhypogammaglobulinemia (HP:0003139) | 2.33649575 |
| 91 | Recurrent otitis media (HP:0000403) | 2.30027316 |
| 92 | Prolonged bleeding time (HP:0003010) | 2.27841486 |
| 93 | Abnormality of the pleura (HP:0002103) | 2.27300147 |
| 94 | Agammaglobulinemia (HP:0004432) | 2.26254046 |
| 95 | Cellular immunodeficiency (HP:0005374) | 2.22710081 |
| 96 | Cerebral palsy (HP:0100021) | 2.21421194 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 2.21072427 |
| 98 | Congenital stationary night blindness (HP:0007642) | 2.19619629 |
| 99 | Polyneuropathy (HP:0001271) | 2.17854878 |
| 100 | Keratitis (HP:0000491) | 2.17693938 |
| 101 | Periodontitis (HP:0000704) | 2.17182794 |
| 102 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16753531 |
| 103 | Abnormality of sodium homeostasis (HP:0010931) | 2.15804983 |
| 104 | Autoimmune thrombocytopenia (HP:0001973) | 2.13896283 |
| 105 | Granulocytopenia (HP:0001913) | 2.13805358 |
| 106 | Increased muscle lipid content (HP:0009058) | 2.13506674 |
| 107 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.10789841 |
| 108 | Trigonocephaly (HP:0000243) | 2.08494497 |
| 109 | Lymphopenia (HP:0001888) | 2.07851649 |
| 110 | Increased hepatocellular lipid droplets (HP:0006565) | 2.06866796 |
| 111 | Thrombophlebitis (HP:0004418) | 2.05682751 |
| 112 | Abnormality of T cell physiology (HP:0011840) | 2.05657078 |
| 113 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.05643832 |
| 114 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.05643832 |
| 115 | Hypergammaglobulinemia (HP:0010702) | 2.04456212 |
| 116 | Abnormality of the pericardium (HP:0001697) | 2.03988131 |
| 117 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00305287 |
| 118 | Increased density of long bones (HP:0006392) | 1.99660678 |
| 119 | 3-Methylglutaconic aciduria (HP:0003535) | 1.95944473 |
| 120 | Renal Fanconi syndrome (HP:0001994) | 1.95830027 |
| 121 | Arthralgia (HP:0002829) | 1.95706682 |
| 122 | Increased mean platelet volume (HP:0011877) | 1.95152272 |
| 123 | Oral leukoplakia (HP:0002745) | 1.95111483 |
| 124 | Gingival bleeding (HP:0000225) | 1.92599960 |
| 125 | Acute necrotizing encephalopathy (HP:0006965) | 1.83818449 |
| 126 | Bronchiectasis (HP:0002110) | 1.83546014 |
| 127 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.81097031 |
| 128 | Purpura (HP:0000979) | 1.78536507 |
| 129 | Skin rash (HP:0000988) | 1.77479954 |
| 130 | Erythema (HP:0010783) | 1.77377381 |
| 131 | Diplopia (HP:0000651) | 1.77326990 |
| 132 | Abnormality of binocular vision (HP:0011514) | 1.77326990 |
| 133 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75562231 |
| 134 | Papilloma (HP:0012740) | 1.75251547 |
| 135 | Verrucae (HP:0200043) | 1.75251547 |
| 136 | Generalized aminoaciduria (HP:0002909) | 1.74976685 |
| 137 | Spondylolisthesis (HP:0003302) | 1.74257765 |
| 138 | Mediastinal lymphadenopathy (HP:0100721) | 1.74165614 |
| 139 | Radial bowing (HP:0002986) | 1.73520511 |
| 140 | Abnormal foot bone ossification (HP:0010675) | 1.72951372 |
| 141 | Lipid accumulation in hepatocytes (HP:0006561) | 1.66230478 |
| 142 | Hepatocellular necrosis (HP:0001404) | 1.64121669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 9.76317576 |
| 2 | MAP4K1 | 4.16635808 |
| 3 | ITK | 3.22832693 |
| 4 | JAK1 | 3.08635282 |
| 5 | STK10 | 3.08393662 |
| 6 | GRK7 | 2.93800381 |
| 7 | JAK3 | 2.73434205 |
| 8 | MST4 | 2.42552875 |
| 9 | ZAP70 | 2.33906299 |
| 10 | TESK2 | 2.25178320 |
| 11 | CSK | 1.93918879 |
| 12 | FES | 1.89391724 |
| 13 | TYK2 | 1.87921028 |
| 14 | LCK | 1.72731753 |
| 15 | VRK2 | 1.69005876 |
| 16 | GRK6 | 1.67819369 |
| 17 | CLK1 | 1.60062412 |
| 18 | ADRBK2 | 1.55793142 |
| 19 | BCKDK | 1.52522038 |
| 20 | PRKCH | 1.51103883 |
| 21 | MAP3K11 | 1.47847116 |
| 22 | SCYL2 | 1.45086965 |
| 23 | MAP3K10 | 1.44080535 |
| 24 | LRRK2 | 1.41162992 |
| 25 | TRIB3 | 1.37344594 |
| 26 | SYK | 1.36604163 |
| 27 | ZAK | 1.35041688 |
| 28 | EPHB1 | 1.27971036 |
| 29 | PRKCQ | 1.27284720 |
| 30 | CDC7 | 1.25175474 |
| 31 | RIPK4 | 1.19779527 |
| 32 | KDR | 1.16573699 |
| 33 | TLK1 | 1.14332557 |
| 34 | TNK2 | 1.14048218 |
| 35 | RIPK1 | 1.11806451 |
| 36 | TTN | 1.10675920 |
| 37 | BTK | 1.03701027 |
| 38 | VRK1 | 1.02357843 |
| 39 | PIK3CA | 1.01583237 |
| 40 | DMPK | 1.00948910 |
| 41 | BLK | 1.00392528 |
| 42 | CDK4 | 0.99817925 |
| 43 | FGFR4 | 0.95828589 |
| 44 | MAPKAPK3 | 0.93674940 |
| 45 | MAP3K14 | 0.93534478 |
| 46 | FGFR3 | 0.91410604 |
| 47 | PIM1 | 0.91408478 |
| 48 | TAOK3 | 0.88429300 |
| 49 | EEF2K | 0.87559403 |
| 50 | MYLK | 0.86857076 |
| 51 | TYRO3 | 0.85930529 |
| 52 | HCK | 0.84881172 |
| 53 | DAPK1 | 0.81075528 |
| 54 | JAK2 | 0.80759193 |
| 55 | SIK2 | 0.80559716 |
| 56 | STK24 | 0.76161065 |
| 57 | ALK | 0.76014202 |
| 58 | GRK1 | 0.75493515 |
| 59 | TBK1 | 0.72020583 |
| 60 | MARK3 | 0.68783058 |
| 61 | BUB1 | 0.66744021 |
| 62 | IKBKE | 0.63257966 |
| 63 | WNK4 | 0.61943370 |
| 64 | LYN | 0.61570092 |
| 65 | ROCK1 | 0.60912144 |
| 66 | PDGFRB | 0.60149295 |
| 67 | NUAK1 | 0.60042953 |
| 68 | TEC | 0.58273466 |
| 69 | NEK2 | 0.55835159 |
| 70 | MUSK | 0.55138970 |
| 71 | CSF1R | 0.54142047 |
| 72 | GRK5 | 0.54019578 |
| 73 | MAP2K6 | 0.53082262 |
| 74 | BMPR2 | 0.52747371 |
| 75 | RPS6KA4 | 0.51092525 |
| 76 | MAP4K2 | 0.50483925 |
| 77 | FYN | 0.50332391 |
| 78 | PIK3CG | 0.49909884 |
| 79 | TESK1 | 0.48903072 |
| 80 | MAP3K7 | 0.48735329 |
| 81 | CDK12 | 0.48557294 |
| 82 | MELK | 0.48414277 |
| 83 | CDK9 | 0.48115339 |
| 84 | INSR | 0.45839218 |
| 85 | ILK | 0.44664311 |
| 86 | FRK | 0.43577183 |
| 87 | TGFBR2 | 0.43511627 |
| 88 | IGF1R | 0.41146556 |
| 89 | HIPK2 | 0.40090474 |
| 90 | KIT | 0.39460855 |
| 91 | PAK1 | 0.38141319 |
| 92 | MAP3K8 | 0.37698633 |
| 93 | PDK1 | 0.36519471 |
| 94 | EPHA3 | 0.35704136 |
| 95 | NLK | 0.35588048 |
| 96 | PTK6 | 0.35553324 |
| 97 | FGR | 0.35164758 |
| 98 | AURKA | 0.34799886 |
| 99 | CDK6 | 0.33821422 |
| 100 | IRAK4 | 0.32956282 |
| 101 | MAP3K5 | 0.32861249 |
| 102 | MAP3K12 | 0.32531156 |
| 103 | PTK2 | 0.32080717 |
| 104 | CAMKK2 | 0.31173840 |
| 105 | PASK | 0.31007773 |
| 106 | PRKCA | 0.30760933 |
| 107 | ADRBK1 | 0.30560645 |
| 108 | OBSCN | 0.30346307 |
| 109 | PRKG2 | 0.30261535 |
| 110 | INSRR | 0.29090982 |
| 111 | RPS6KA5 | 0.28007938 |
| 112 | GSK3A | 0.27982835 |
| 113 | TRPM7 | 0.26847544 |
| 114 | STK16 | 0.26523461 |
| 115 | BMX | 0.25917451 |
| 116 | EIF2AK3 | 0.25666506 |
| 117 | TIE1 | 0.25348126 |
| 118 | RPS6KA6 | 0.24106266 |
| 119 | PAK4 | 0.24021054 |
| 120 | ROCK2 | 0.23245032 |
| 121 | STK4 | 0.22744582 |
| 122 | RAF1 | 0.22603660 |
| 123 | RPS6KL1 | 0.22489764 |
| 124 | RPS6KC1 | 0.22489764 |
| 125 | CSNK1A1L | 0.22087960 |
| 126 | MAPK11 | 0.21572791 |
| 127 | CDK8 | 0.21510277 |
| 128 | STK39 | 0.21098778 |
| 129 | ABL1 | 0.20615354 |
| 130 | OXSR1 | 0.19654418 |
| 131 | PRKCD | 0.19445226 |
| 132 | MAPK13 | 0.19073726 |
| 133 | SRC | 0.18547923 |
| 134 | PKN2 | 0.18410408 |
| 135 | IKBKB | 0.18230984 |
| 136 | PRKACA | 0.17324160 |
| 137 | MAPK12 | 0.17177018 |
| 138 | MAPKAPK2 | 0.16769976 |
| 139 | CSNK1G3 | 0.16309308 |
| 140 | PRKCB | 0.16119119 |
| 141 | ACVR1B | 0.16101025 |
| 142 | MAPK4 | 0.15710117 |
| 143 | LIMK1 | 0.15642307 |
| 144 | MAPK7 | 0.14888073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 8.43616520 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 5.67616871 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 5.05875710 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.65662265 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.57339800 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.29544009 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.14911719 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.13328101 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 2.71501172 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.42863480 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.33010057 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.24889759 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 1.94733077 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85750389 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.67246115 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66736444 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56038228 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.46375694 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.41647085 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.35854339 |
| 21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34587412 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.22573949 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13914686 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08862473 |
| 25 | Apoptosis_Homo sapiens_hsa04210 | 1.07812130 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06188087 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.00558098 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00104804 |
| 29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98105960 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98085434 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97590166 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97272363 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90893354 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 0.88921250 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 0.87688522 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85084959 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84856159 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84825871 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84098269 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 0.83846100 |
| 41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83529766 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83232675 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 0.82300223 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 0.78690218 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77407720 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73741411 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72661628 |
| 48 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69122024 |
| 49 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69011321 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.67321266 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62498001 |
| 52 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56651360 |
| 53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56505895 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55501431 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 0.54507375 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53531335 |
| 57 | Protein export_Homo sapiens_hsa03060 | 0.52758213 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52313345 |
| 59 | DNA replication_Homo sapiens_hsa03030 | 0.52241117 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51280862 |
| 61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.49699237 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49422704 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.48662210 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46780198 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45580232 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.45282347 |
| 67 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44946958 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43897191 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.43817766 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43697620 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42632321 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.40776455 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.40679148 |
| 74 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40466196 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39423871 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39260503 |
| 77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.38919041 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38671564 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38489676 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38479645 |
| 81 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34387171 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34029793 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33884912 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33166065 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33013154 |
| 86 | Focal adhesion_Homo sapiens_hsa04510 | 0.32906947 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.30907585 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.30278672 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27945397 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26344793 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25522928 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25003489 |
| 93 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.24367269 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.24274519 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.23902855 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.23520933 |
| 97 | Mismatch repair_Homo sapiens_hsa03430 | 0.23158310 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.23054781 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22824246 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.22512812 |
| 101 | Ribosome_Homo sapiens_hsa03010 | 0.21234478 |
| 102 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.21179852 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.20877984 |
| 104 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19631652 |
| 105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.19415289 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.18930653 |
| 107 | Purine metabolism_Homo sapiens_hsa00230 | 0.18408521 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17033822 |
| 109 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.13703792 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.13471449 |
| 111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.12712815 |
| 112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.12625414 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12181862 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.11693915 |
| 115 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.11469247 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.11397772 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.11345010 |
| 118 | Long-term potentiation_Homo sapiens_hsa04720 | 0.11318983 |
| 119 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.10246718 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.10140159 |
| 121 | ABC transporters_Homo sapiens_hsa02010 | 0.08629356 |
| 122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.08288712 |
| 123 | Spliceosome_Homo sapiens_hsa03040 | 0.08184756 |
| 124 | Renin secretion_Homo sapiens_hsa04924 | 0.06884777 |
| 125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.06209651 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.05670634 |
| 127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.05373417 |
| 128 | Homologous recombination_Homo sapiens_hsa03440 | 0.04416788 |
| 129 | Cell cycle_Homo sapiens_hsa04110 | 0.04195630 |
| 130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.04172157 |
| 131 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.03562778 |
| 132 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.03538373 |
| 133 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.03336523 |
| 134 | Glioma_Homo sapiens_hsa05214 | 0.02923284 |
| 135 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.02451153 |
| 136 | Adherens junction_Homo sapiens_hsa04520 | 0.02243077 |
| 137 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.01944769 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.01562040 |
| 139 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.01101601 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.00885292 |
| 141 | Ras signaling pathway_Homo sapiens_hsa04014 | -0.0086348 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | -0.0082254 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0038304 |
| 144 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | -0.0027289 |
| 145 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0014719 |

